eye drops delay, will prevent, myopia

Published Date: 16 Feb 2023

Researchers have found that dilating eye drops that children use daily can delay the onset of myopia.

Read Full News

Latest News

Endophthalmitis a Risk for Years After Tube Shunt Surgery

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds.

Trabeculectomy Often More Cost-Effective Than Tube Shunts

Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma.

Common Epilepsy Drug Tied to Increased Glaucoma Risk

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Worsening Heart-Kidney-Metabolic Health May Threaten Vision

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Study Maps Extensive Disease Links Beyond Childhood Eczema

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Latest News

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds.

Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma.

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

News All Time

FDA Issues Complete Response Letter for ONS-5010 for Wet AMD

FDA Issues Complete Response Letter for ONS-5010 for Wet AMD

Ophthalmology in 2025: Year in Review

Ophthalmology in 2025: Year in Review

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

New Parameters for Faster Geographic Atrophy Progression Established, with Srinivas Sadda, MD Srinivas Sadda, MD

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD Dante J. Pieramici, MD

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

Psoriasis Associated with Risk of Age-Related Macular Degeneration Ryan Livingston

Based on 3 propensity-matched control groups, patients with psoriasis can have anywhere from a 40% to 56% higher risk.

Correlation Between Diabetes and Risk of Uveitis Confirmed in Recent Study Ryan Livingston

In addition to type 1 and 2 diabetes, diabetic retinopathy substantially increases the risk of developing and worsening uveitis.

Q3 2025 Recap: Ophthalmology News and Updates Ryan Livingston

The Q3 recap for ophthalmology spotlights major FDA decisions and major clinical trial updates in a variety of diseases.

FDA Approves Incision-Free Topical Therapy Epioxa for Keratoconus Ryan Livingston

This approval represents an alternative method for approaching this undertreated disease, shortening recovery while minimizing invasiveness.

Dyslipidemia May Delay Macular Hole Closure After Surgery Ryan Livingston

A recent study highlights correlations between later healing, triglyceride levels, and total cholesterol in patients receiving MH.

FDA Approves Adalimumab-aaty (Yuflyma) Pediatric Indications in Hidradenitis Suppurativa, Uveitis Abigail Brooks, MA

The FDA approved expanded indications for adalimumab-aaty (Yuflyma) and its unbranded version to include the treatment of adolescent HS and pediatric UV.

GLP-1 RAs May Influence Development of Nonexudative AMD in Patients With Obesity Ryan Livingston

Although no direct correlation can be drawn, these findings suggest a possible ocular benefit from GLP-1 RAs compared to other weight loss drugs.

Brolucizumab Outperforms Aflibercept in DME Regardless of Prior Treatment

Brolucizumab Outperforms Aflibercept in DME Regardless of Prior Treatment

Recommended News For You

Research discovery halts childhood brain tumor before it forms

Should the UK introduce targeted prostate cancer screening? The case for and against

When Should Immunocompromised Individuals Receive a COVID Booster?

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

Approved BTK Inhibitor Without Covalent Bond for CLL.

Psychiatric Disorders Are Common in Dementia Patients.

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

Recommended Articles For You

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link 

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care 

Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

4.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

5.

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

1.

The New Era of Oncology: Key Updates and Clinical Insights

2.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

3.

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes

4.

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment

5.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

2.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

4.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot